The Effects of Acute and Chronic Selective Phosphodiesterase 1 Inhibition on Smooth Muscle Cell-Associated Aging Features

The Effects of Acute and Chronic Selective Phosphodiesterase 1 Inhibition on Smooth Muscle Cell-Associated Aging Features

Age-related cardiovascular diseases (CVDs) remain among the leading global causes of death, and vascular smooth muscle cell (VSMC) remodeling plays an essential role in its pathology. Reduced NO-cGMP pathway signaling is a major feature and pathogenic mechanism underlying vasodilator dysfunction. Re...

Full description

Bibliographic Details
Main Authors:	Keivan Golshiri, Ehsan Ataei Ataabadi, Annika A. Jüttner, Gretchen L. Snyder, Robert E Davis, Amy Lin, Lei Zhang, René de Vries, Ingrid M Garrelds, Frank P. J. Leijten, A. H. Jan Danser, Anton J. M. Roks
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-01-01
Series:	Frontiers in Pharmacology
Subjects:	phosphodiesterase vascular aging smooth muscle cell cardiovascular NO-cGMP pathway inflammation
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2021.818355/full

Similar Items

Chronic Sildenafil Treatment Improves Vasomotor Function in a Mouse Model of Accelerated Aging
by: Keivan Golshiri, et al.
Published: (2020-06-01)

Optogenetic manipulation of cyclic guanosine monophosphate to probe phosphodiesterase activities in megakaryocytes
by: Yujing Zhang, et al.
Published: (2022-08-01)

Regulation of the renin-angiotensin-aldosterone system by cyclic nucleotides and phosphodiesterases
by: Stepan Gambaryan, et al.
Published: (2023-08-01)

Characterization and Modification of Light-Sensitive Phosphodiesterases from Choanoflagellates
by: Yuehui Tian, et al.
Published: (2022-01-01)

Role of Phosphodiesterase in the Biology and Pathology of Diabetes
by: Agnieszka Kilanowska, et al.
Published: (2020-11-01)

Phosphodiesterases regulate BAY 41-2272-induced VASP phosphorylation in vascular smooth muscle cells
by: Shaquria P Adderley, et al.
Published: (2012-02-01)

Apicomplexan phosphodiesterases in cyclic nucleotide turnover: conservation, function, and therapeutic potential
by: William J. Moss, et al.
Published: (2024-02-01)

Once upon a Testis: The Tale of Cyclic Nucleotide Phosphodiesterase in Testicular Cancers
by: Federica Campolo, et al.
Published: (2023-04-01)

Advances, Perspectives and Potential Engineering Strategies of Light-Gated Phosphodiesterases for Optogenetic Applications
by: Yuehui Tian, et al.
Published: (2020-10-01)

Rise of cGMP by partial phosphodiesterase-3A degradation enhances cardioprotection during hypoxia
by: Nadja I. Bork, et al.
Published: (2021-12-01)

Phosphodiesterase and psychiatric disorders: a two-sample Mendelian randomization study
by: Miaomiao Jiang, et al.
Published: (2023-08-01)

Cardiorenal Effects of Long‐Term Phosphodiesterase V Inhibition in Pre–Heart Failure
by: Scott A. Hubers, et al.
Published: (2022-01-01)

Advancements in Phosphodiesterase 5 Inhibitors: Unveiling Present and Future Perspectives
by: Ahmed K. ElHady, et al.
Published: (2023-09-01)

Plasticity and therapeutic potential of cAMP and cGMP-specific phosphodiesterases in Toxoplasma gondii
by: Kim Chi Vo, et al.
Published: (2022-01-01)

Sub-nanomolar sensitivity of nitric oxide mediated regulation of cGMP and vasomotor reactivity in vascular smooth muscle
by: Kara F. Held, et al.
Published: (2012-07-01)

Compartmentation of cGMP Signaling in Induced Pluripotent Stem Cell Derived Cardiomyocytes during Prolonged Culture
by: Maria Faleeva, et al.
Published: (2022-10-01)

Upregulation of Phosphodiesterase 2A Augments T Cell Activation by Changing cGMP/cAMP Cross-Talk
by: Roberta Kurelic, et al.
Published: (2021-10-01)

In Search of Monocot Phosphodiesterases: Identification of a Calmodulin Stimulated Phosphodiesterase from <i>Brachypodium distachyon</i>
by: Mateusz Kwiatkowski, et al.
Published: (2021-09-01)

Phosphodiesterases in the Liver as Potential Therapeutic Targets of Cirrhotic Portal Hypertension
by: Wolfgang Kreisel, et al.
Published: (2020-08-01)

The Sleep Quality- and Myopia-Linked PDE11A-Y727C Variant Impacts Neural Physiology by Reducing Catalytic Activity and Altering Subcellular Compartmentalization of the Enzyme
by: Irina Sbornova, et al.
Published: (2023-12-01)

Phosphodiesterase 9A in Brain Regulates cGMP Signaling Independent of Nitric-Oxide
by: John F. Harms, et al.
Published: (2019-08-01)

Effect of phosphodiesterase inhibitors in the bladder
by: Bilal Chughtai, et al.
Published: (2015-01-01)

Dysregulated Cyclic Nucleotide Metabolism in Alcohol-Associated Steatohepatitis: Implications for Novel Targeted Therapies
by: Diego Montoya-Durango, et al.
Published: (2023-10-01)

Multi-Compartment, Early Disruption of cGMP and cAMP Signalling in Cardiac Myocytes from the <i>mdx</i> Model of Duchenne Muscular Dystrophy
by: Marcella Brescia, et al.
Published: (2020-09-01)

Imaging of PDE2- and PDE3-Mediated cGMP-to-cAMP Cross-Talk in Cardiomyocytes
by: Nikoleta Pavlaki, et al.
Published: (2018-01-01)

Role of Phosphodiesterase 1 in the Regulation of Real-Time cGMP Levels and Contractility in Adult Mouse Cardiomyocytes
by: Nadja I. Bork, et al.
Published: (2023-12-01)

A mini-review: phosphodiesterases in charge to balance intracellular cAMP during T-cell activation
by: Marie Bielenberg, et al.
Published: (2024-03-01)

Cellular Redox Metabolism Is Modulated by the Distinct Localization of Cyclic Nucleotide Phosphodiesterase 5A Isoforms
by: Silvia Cardarelli, et al.
Published: (2022-08-01)

Clinical utility of plecanatide in the treatment of chronic idiopathic constipation
by: Islam BN, et al.
Published: (2018-08-01)

Hyperammonemia impairs long-term potentiation in hippocampus by altering the modulation of cGMP-degrading phosphodiesterase by protein kinase G
by: Pilar Monfort, et al.
Published: (2004-02-01)

PDE-Mediated Cyclic Nucleotide Compartmentation in Vascular Smooth Muscle Cells: From Basic to a Clinical Perspective
by: Margarida Lorigo, et al.
Published: (2021-12-01)

Identification of new signaling components in the sensory epithelium of human saccule
by: Eva eDegerman, et al.
Published: (2011-08-01)

The Complexity and Multiplicity of the Specific cAMP Phosphodiesterase Family: PDE4, Open New Adapted Therapeutic Approaches
by: Claire Lugnier
Published: (2022-09-01)

A Dual-Acting Nitric Oxide Donor and Phosphodiesterase 5 Inhibitor Activates Autophagy in Primary Skin Fibroblasts
by: Esther Martínez-Martínez, et al.
Published: (2022-06-01)

Functions of PDE3 Isoforms in Cardiac Muscle
by: Matthew Movsesian, et al.
Published: (2018-02-01)

Analysis of <it>PDE6D </it>and <it>PDE6G </it>genes for generalised progressive retinal atrophy (gPRA) mutations in dogs
by: Dekomien Gabriele, et al.
Published: (2003-07-01)

Pros and Cons of Pharmacological Manipulation of cGMP-PDEs in the Prevention and Treatment of Breast Cancer
by: Patrizia Di Iorio, et al.
Published: (2021-12-01)

Repurposing Phosphodiesterase-5 inhibitors as chemoadjuvants
by: Amit K. Tiwari, et al.
Published: (2013-06-01)

Control of Vascular Smooth Muscle Cell Growth by Connexin 43
by: Chintamani eJoshi, et al.
Published: (2012-06-01)

Comparative analysis of diguanylate cyclase and phosphodiesterase genes in <it>Klebsiella pneumoniae</it>
by: Cruz Diana P, et al.
Published: (2012-07-01)